FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to a stable composition in the form of oral emulsion containing at least 50% of water, 0.2 to 3 wt % of oil containing at least 12 wt % of docosahexaenoic acid and eicosapentaenoic acid, an antioxidant, an aromatiser and at least 0.01 wt % of edible phospholipid emulsifier.
EFFECT: oral stable emulsion visible skin if used on a regular basis.
8 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PERORAL COMPOSITION WITH EFFECT AIMED AGAINST SKIN AGING | 2007 |
|
RU2434642C2 |
| ORAL COMPOSITION WITH ANTI-AGEING SKIN EFFECT | 2010 |
|
RU2533277C2 |
| COMPOSITION AND METHOD OF INCREASING STABILITY OF ADDITIVES TO FOOD PRODUCTS | 2012 |
|
RU2592572C2 |
| METHOD AND PREPARATION FOR THE TREATMENT OR PREVENTION OF ANXIETY OR NEUROGENESIS | 2010 |
|
RU2606841C2 |
| CHOCOLATE PRODUCT CONTAINING HIGHLY UNSATURATED FATTY ACIDS | 2017 |
|
RU2736152C2 |
| OPHTHALMOLOGICAL COMPOSITION, BASED ON POLYUNSATURATED FATTY ACIDS OMEGA-3 AND OMEGA-6 | 2010 |
|
RU2545675C2 |
| BALANCED FAT COMPOSITIONS AND THEIR APPLICATION IN LIQUID NUTRITIONAL COMPOSITIONS FOR ENTERAL FEEDING | 2010 |
|
RU2546865C2 |
| POWDERED COMPOSITION, ITS PRODUCTION METHOD AND USAGE | 2005 |
|
RU2374859C2 |
| METHODS FOR MANUFACTURING NUTRITIONAL COMPOSITIONS | 2017 |
|
RU2777978C2 |
| CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | 2010 |
|
RU2755902C2 |
